Cormedix Inc (CRMD)
5.515
+0.26
(+4.85%)
USD |
NASDAQ |
May 01, 16:00
5.515
0.00 (0.00%)
After-Hours: 19:52
Cormedix Cash from Financing (Quarterly): 0.4677M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4677M |
| September 30, 2023 | 42.90M |
| June 30, 2023 | 5.350M |
| March 31, 2023 | 7.200M |
| December 31, 2022 | 6.046M |
| September 30, 2022 | 0.4373M |
| June 30, 2022 | 8.411M |
| March 31, 2022 | 3.004M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.177M |
| March 31, 2021 | 41.58M |
| December 31, 2020 | 15.32M |
| September 30, 2020 | 21.94M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 2.835M |
| December 31, 2019 | -0.2059M |
| September 30, 2019 | 10.03M |
| June 30, 2019 | 0.0138M |
| March 31, 2019 | 15.97M |
| December 31, 2018 | 18.38M |
| September 30, 2018 | 6.863M |
| June 30, 2018 | 0.8806M |
| March 31, 2018 | 3.269M |
| December 31, 2017 | 7.372M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 12.80M |
| March 31, 2017 | 0.3542M |
| December 31, 2016 | 0.0224M |
| September 30, 2016 | 4.649M |
| June 30, 2016 | 2.155M |
| March 31, 2016 | 0.266M |
| December 31, 2015 | 1.207M |
| September 30, 2015 | 3.301M |
| June 30, 2015 | 32.29M |
| March 31, 2015 | 6.828M |
| December 31, 2014 | 0.0087M |
| September 30, 2014 | 0.0958M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 8.253M |
| December 31, 2013 | 2.861M |
| September 30, 2013 | 1.843M |
| June 30, 2013 | 0.025M |
| March 31, 2013 | 0.475M |
| December 31, 2012 | 0.3714M |
| September 30, 2012 | 0.77M |
| June 30, 2012 | -0.015M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.2059M
Minimum
Dec 2019
42.90M
Maximum
Sep 2023
8.711M
Average
3.004M
Median
Mar 2022
Cash from Financing (Quarterly) Benchmarks
| BioXcel Therapeutics Inc | 2.123M |
| Assertio Holdings Inc | -8.915M |
| Verastem Inc | -0.446M |
| Ocular Therapeutix Inc | 108.17M |
| PAVmed Inc | 5.288M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.75M |
| Cash from Investing (Quarterly) | 0.5978M |
| Free Cash Flow | -38.74M |
| Free Cash Flow Per Share (Quarterly) | -0.1921 |
| Free Cash Flow Yield | -13.81% |